Chandana, Sreenivasa R
Mayo Clinic
Cancer & Hematology Centers of Western Michigan, Grand Rapids, MI, USA
Citations 12
Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma
Karime, Christian , Wang, Jing , Woodhead, Gregory , Mody, Kabir , Hennemeyer, Charles , Mahadevan, Daruka , Chandana, Sreenivasa R , Borad, Mitesh J. , Babiker, Hani M.
Expert Opinion on Investigational Drugs | December 16, 2021 | Volume: 31 | Issue: 1 | Pages: 1-13
Novel biomarkers for cholangiocarcinoma: how can it enhance diagnosis, prognostication, and investigational drugs? Part-1
Sinniah, Ranuka , Shapses, Mark S, Ahmed, Mohammad Umar, Chandana, Sreenivasa R , Shapses, Mark A., Ahmed, Mohammad Umar, Babiker, Hani M.
Expert Opinion on Investigational Drugs | September 28, 2021 | Volume: 30 | Issue: 10 | Pages: 1047-1056